Maravai LifeSciences (MRVI) Tops Q4 EPS by 2c, Revenues Beat; Offers FY21 EPS/Revenue Guidance Above Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. HOOD
7. DFTX
8. GOOGL
9. MU
10. IBM

Go back to Maravai LifeSciences (MRVI) Tops Q4 EPS by 2c, Revenues Beat; Offers FY21 EPS/Revenue Guidance Above Consensus

Maravai LifeScience Holdings Inc. (MRVI) PT Raised to $34 at Credit Suisse

March 1, 2021 6:10 AM EST

Credit Suisse analyst Erin Wilson Wright raised the price target on Maravai LifeScience Holdings Inc. (NASDAQ: MRVI) to $34.00 (from $31.00) while maintaining a Outperform rating.... More